Patient and nurse

Who we are

We are a registered charity, governed by an independent board of trustees and a director. Find out who they are and what they do.

HRH The Duke of Cambridge with a patient

President of The Royal Marsden
HRH The Duke of Cambridge

Since 2007, HRH The Duke of Cambridge - Prince William - has been President of The Royal Marsden, a position previously held by his mother. The hospital has always been very close to his heart. 

He has visited both hospital sites on numerous occasions, including officially opening the Oak Centre for Children and Young People with his wife HRH The Duchess of Cambridge in 2011.  ​

Our trustees

Our trustees are jointly responsible for running the charity and for making sure that all the funding we receive goes towards achieving the best outcomes for cancer patients at The Royal Marsden and across the UK by continuously driving for excellence in all areas of cancer research, diagnosis, treatment and care. 

Our trustees have a wide range of expertise between them, including within the arts, medicine, law, banking and property.

Charles Alexander - our Chairman

Charles Alexander - Chairman

Charles is Chairman of both The Royal Marsden Cancer Charity and The Royal Marsden NHS Foundation Trust.

Charles has worked at board level across banking, industry and charitable sectors, including NM Rothschild and GE Capital Europe. He is currently the lead non-executive director at the Department of Culture, Media & Sport.

Robin Broadhurst CVO CBE

Robin Broadhurst CVO CBE

Robin spent almost 35 years with Jones Lang LaSalle as a real estate investment adviser, ending up as European Chairman. He is now Chair of Sableknight and a Non-Executive Director of Chelsfield and The Regeneration Group.

Robin was formerly Chair of Grainger plc, a trustee and director of Grosvenor. He is also a trustee of several charities.

Douglas Flint CBE

Sir Douglas Flint CBE

Douglas retired as Group Chairman of HSBC Holdings plc in September 2017, having served on the Board for 22 years, including fifteen years as HSBC’s Group Finance Director.  Between 2005 and 2011 he was also a Non-Executive Director of BP plc. 

In December 2017 he was appointed by the Chancellor as Special Envoy to China’s Belt and Road Initiative. 

In June 2006 Mr Flint was honoured with a CBE and in June 2018 was awarded a Knighthood, both awards in recognition of his services to the finance industry.

Martin Gore

Prof Martin Gore PhD FRCP CBE

Awarded a CBE in 2016 for services to oncology, Martin is a Consultant Medical Oncologist and Professor of Cancer Medicine at The Royal Marsden. Martin has special interests in melanoma, kidney cancers and ovarian cancers, and the development of novel therapies for treating them.

Martin is a commissioner at the Commission on Human Medicines at the Medicines & Healthcare Products Regulatory Agency, chairing their Oncology & Haematology Expert Advisory Group. He is also a member of the Oncology Scientific Advisory Group at the European Medicines Agency.

Sir Terry Leahy

Sir Terry Leahy

Sir Terry Leahy, was appointed Chief Executive of Tesco PLC in March 1997 and retired from this position in March 2011.

He received a Knighthood for services to food retailing in the 2002 New Year Honours and in the same year was made a Freeman of the City of Liverpool and is a member of the Liverpool Enterprise Partnership Advisory Board.

In March 2008 he was nominated by Retail Week as Retail Leader of the Year. From 2005 to 2010 he was voted as Britain’s Most Admired Leader by Management Today and in 2004 he was named European Businessman of the year by Fortune Magazine. In 2010 he received the Daily Telegraph’s Award for a Decade of Excellence in Business a Lifetime Achievement award from Director Magazine and was voted Business Person of the Year by the Sunday Times.

Terry is now a part-time senior advisor to Clayton Dubilier & Rice, the US private equity firm and holds various Chair and Executive Committee memberships.

Richard Oldfield

Richard Oldfield OBE

Richard is Chairman of the boutique investment management firm Oldfield Partners. He was the first Chairman of Oxford University Endowment Management Ltd, from 2007 to 2014, and is a director of Witan Investment Trust plc and Shepherd Neame Ltd.

Richard is a trustee of a number of charities, and is President of Demelza House Children’s Hospice.

Cally Palmer CBE

Cally Palmer CBE

Cally is the Chief Executive of The Royal Marsden NHS Foundation Trust. In 2006 she was awarded a CBE for her contribution to healthcare.

Cally was appointed NHS National Cancer Director for NHS England in 2015, and she has advised the government on national strategy for cancer care.

Lady Helen Taylor

Lady Helen Taylor

Lady Helen Taylor started her art career in 1984 at Christie’s auction house in their Contemporary Department, until 1988 when she became a director of the Karsten Schubert Gallery in London.

In 1996 Helen joined Giorgio Armani as his global ambassador for twelve years and was also an ambassador for the charity CLIC Sargent. She is presently on the Advisory Board of the Glyndebourne Opera House after being a trustee there for six years.

Helen married art dealer Timothy Taylor in 1992 and they have four children.

Richard Turnor

Richard Turnor

Richard is co-founder and partner of the London private client law firm Maurice Turnor Gardner, which also has a charity and philanthropy practice. He is an adviser on partnership law and practice. From 1985 to 2009 he was a partner at the international law firm Allen & Overy.

Antonia Dalmahoy

Antonia Dalmahoy, Managing Director

After studying Economics at Cambridge, Antonia worked for management consultants McKinsey & Co and then in the strategy department at Thomson Reuters before moving into the voluntary sector. Positions at Marie Curie, Start Here and Great Ormond Street Hospital Children’s Charity followed.

Antonia was at GOSHCC for seven years, before joining us at The Royal Marsden Cancer Charity as our director in 2015.

How you help

Our trustees may make the decisions about where to allocate funds, but none of this would be possible without people like you. With your help we raise the money needed to help the hospital provide the latest research, diagnosis, treatment and care for our patients.

You help make it happen. Find out what can be achieved when you decide to get involved.